CASI Pharmaceuticals (DE:ENM)
STUTTGART:ENM
Holding DE:ENM?
Track your performance easily

CASI Pharmaceuticals (ENM) Income Statement

0 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q ), CASI Pharmaceuticals's total revenue was $15.32M, an increase of 67.27% from the same quarter last year. In Q, CASI Pharmaceuticals's net income was $-19.54M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 43.17M$ 43.11M$ 30.17M$ 15.14M$ 4.13M$ 0.00
Cost of Revenue
$ 38.94M$ 15.83M$ 12.56M$ 9.51M$ 3.94M$ 0.00
Gross Profit
$ 27.28M$ 27.28M$ 17.61M$ 5.63M$ 196.00K$ 0.00
Operating Expense
$ 53.77M$ 53.77M$ 52.89M$ 38.95M$ 39.78M$ 26.50M
Operating Income
$ -26.49M$ -26.49M$ -35.28M$ -33.31M$ -39.58M$ -26.50M
Net Non Operating Interest Income Expense
$ 114.00K-$ 321.00K$ 866.00K$ 1.06M$ 40.00K
Other Income Expense
$ 2.80M$ 6.43M$ -881.00K$ -15.06M$ -6.84M$ -1.01M
Pretax Income
$ -37.43M$ -37.43M$ -35.84M$ -47.51M$ -45.36M$ -27.47M
Tax Provision
$ 1.98M$ 1.98M$ 0.00$ 0.00--
Earnings From Equity Interest Net Of Tax
$ 4.48M$ 4.48M----
Net Income Common Stockholders
$ -41.01M$ -41.01M$ -36.65M$ -48.29M$ -46.03M$ -27.47M
Basic EPS
$ -1.16--$ -4.40--
Diluted EPS
$ -1.16--$ -4.40--
Basic Average Shares
$ 27.40M--$ 11.05M--
Diluted Average Shares
$ 27.40M--$ 11.05M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 92.71M$ 69.60M$ 65.45M$ 48.45M$ 43.71M$ 26.50M
Net Income From Continuing And Discontinued Operation
$ -41.01M$ -41.01M$ -36.65M$ -48.29M$ -46.03M$ -27.47M
Normalized Income
$ -15.26M-$ -35.22M$ -33.14M$ -39.19M$ -26.46M
Interest Expense
----$ -1.06M$ -40.00K
EBIT
$ -36.59M$ -37.56M$ -35.28M$ -33.31M$ -39.58M$ -27.51M
EBITDA
$ -29.92M$ -35.14M$ -33.47M$ -31.35M$ -37.43M$ -25.84M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis